Consolidated Statement Of Comprehensive Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7326592

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
6,364,000,000 JPY
5,536,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,787,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
185,000,000 JPY
-63,000,000 JPY
Deferred gains or losses on hedges
0 JPY
0 JPY
Foreign currency translation adjustment
166,000,000 JPY
147,000,000 JPY
Remeasurements of defined benefit plans, net of tax
153,000,000 JPY
11,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
434,000,000 JPY
JPY
Other comprehensive income
939,000,000 JPY
94,000,000 JPY
Comprehensive income
6,475,000,000 JPY
3,881,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
6,430,000,000 JPY
3,834,000,000 JPY
Comprehensive income attributable to non-controlling interests
44,000,000 JPY
46,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.